[ad_1] Glenmark Pharmaceuticals Ltd on Thursday (March 20) said its arms Pharmaceuticals Inc., USA, has received final approval from the US Food & Drug Administration (USFDA) for its Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC). The product has been determined to be bioequivalent to Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC), developed by Alcon […]
Glenmark Pharma shares jump up to 4% on Phase 1 results for blood cancer drug – CNBC TV18
[ad_1] Shares of Glenmark Pharma Ltd. gained up to 4% on Tuesday, December 10, following first clinical data from the Phase 1 studi of a cancer treating drug. Company Value Change %Change Glenmark in an exchange filing said that the first clinical data from Phase 1 study of Trispecific TREAT Antibody, ISB 2001, showed a […]
Glenmark Pharma Q2 Results | Drug firm returns to profit, revenue up 7% – CNBC TV18
[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Thursday (November 14) reported a net profit of ₹354.4 crore for the second quarter that ended September 30, 2024. In the corresponding quarter of the previous fiscal, Glenmark Pharmaceuticals posted a net loss of ₹180.2 crore, the company said in a regulatory filing. Revenue from operations increased 7.1% […]
Glenmark Pharmaceuticals Q1 net profit zooms to ₹340 crore, revenue up 7% – CNBC TV18
[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Wednesday (August 14) reported over two-fold increase in consolidated net profit to ₹340.2 crore for the first quarter that ended June 30, 2024. In the corresponding quarter, Glenmark Pharmaceuticals posted a net profit of ₹37.7 crore, the company said in a regulatory filing. The company reported consolidated profit […]